🔎 Trials Near Me

Gara Jalqabaatti › Inflammatory Bowel Disease › New York

Qorannoo klinikaalii Inflammatory Bowel Disease New York keessatti

Qorannoo 21 Inflammatory Bowel Disease f New York keessatti hirmaatuu jiru.

Magaalota New York keessatti

Takkalaa qorannoo (Ingiliffa)

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

  • NYU Langone Hospital - Long Island, Mineola
  • Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York
  • NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
  • fi 1 dabalataa
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT03816345

A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis

  • Ellipsis Research Group, Brooklyn
  • Smart Medical Research - Jackson Heights, Jackson Heights
  • Pioneer Clinical Research NY, New York
  • fi 1 dabalataa
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 hanga 75 · Saalaa hunda · Haaromfame 30-Ful-2026 · NCT06598943

A Trial to Investigate PALI-2108 Versus Placebo in Participants With Moderately to Severely Active Ulcerative Colitis

  • Site US-002, Albany
  • Site US-016, Rochester
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 hanga 75 · Saalaa hunda · Haaromfame 29-Ful-2026 · NCT07845487

A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis

  • Site 037, New York
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 hanga 75 · Saalaa hunda · Haaromfame 29-Ful-2026 · NCT07012395

Study of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis

  • Xencor Investigative Site, Albany
  • Xencor Investigative Site, Rochester
Namoota walitti qabaa jiraSadarkaa 1/2Hojjettoota fayyaa simatamoo
Umuriin 18 hanga 75 · Saalaa hunda · Haaromfame 29-Ful-2026 · NCT06619990

A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease

  • Weill Cornell Medical College - Judith Jaffe Multiple Sclerosis Center, New York
  • Icahn School of Medicine at Mount Sinai, New York
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 2 hanga 17 · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT05923073

A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)

  • Icahn School of Medicine at Mount Sinai, New York
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 2 hanga 19 · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT04844606

A Study to Measure Mirikizumab Levels in Breast Milk of Lactating Participants Receiving Mirikizumab Therapeutically for an Approved Indication

  • Digestive Disease Medicine of Central New York, Utica
Namoota walitti qabaa jiraSadarkaa 4
3 Weeks · Dubartoota · Haaromfame 08-Ful-2026 · NCT07612267

A Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's Disease

  • Weill Cornell Medical College (WCMC) - Judith Jaffe Multiple Sclerosis Center (JJMSC), New York
  • Icahn School of Medicine at Mount Sinai, New York
  • Columbia University Medical Center/New York Presbyterian, New York
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 2 hanga 17 · Saalaa hunda · Haaromfame 24-Hag-2026 · NCT05509777

Testing the Role of Anti-fungal Therapy in Improving the Response to Therapies for Crohn's Disease

  • Weill Cornell Medicine, New York
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 20-Hag-2026 · NCT06274554

BOOM-IBD2 Pivotal Clinical Trial

  • Northwell Health North Shore University Hospital, Manhasset
  • Columbia University Irving Medical Center/New York Presbyterian Hospital, New York
Namoota walitti qabaa jira
Umuriin 18 hanga 85 · Saalaa hunda · Haaromfame 06-Hag-2026 · NCT06571669

Social Determinants of Health, Medication Use, and Quality of Life in Inflammatory Bowel Disease

  • Icahn School of Medicine at Mount Sinai, New York
  • Montefiore Hutchinson Campus, The Bronx
Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 05-Hag-2026 · NCT06266663

Zymfentra (Infliximab-dyyb) REal World Cohort STudy

  • New York University, New York
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 05-Hag-2026 · NCT07237516

Low Dose IL-2 for the Treatment of Crohn's Disease

  • Mount Sinai, New York
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 12 hanga 80 · Saalaa hunda · Haaromfame 03-Hag-2026 · NCT04263831

Autologous Stem Cell Transplant for Crohn's Disease

  • Icahn School of Medicine at Mount Sinai, New York
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 24-Ado-2026 · NCT03219359

Clinical, Imaging, and Endoscopic Outcomes of Children Newly Diagnosed With Crohn's Disease

  • Cohen Children's Medical Center of NY, Lake Success
  • Columbia University Medical Center, New York
Namoota walitti qabaa jiraSadarkaa 4
Umuriin 6 hanga 17 · Saalaa hunda · Haaromfame 27-Cam-2026 · NCT05781152

Impact of Morning Light Therapy in IBD

  • Mount Sinai Hospital, New York
Namoota walitti qabaa jira
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 13-Bit-2026 · NCT07207200

A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease

  • Mirador Therapeutics Selected Site, New York
  • Mirador Therapeutics Selected Site, Rochester
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 hanga 80 · Saalaa hunda · Haaromfame 12-Bit-2026 · NCT07113522

Pre-operative Nutrition for Elective Resection Surgery in Inflammatory Bowel Disease

  • NYU Langone Health, New York
Namoota walitti qabaa jira
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 05-Bit-2026 · NCT06309017

Pregnant Women With and Without Crohns Disease to Explore the Role of Plastics and Toxins in Intestinal Inflammation

  • Icahn School of Medicine at Mount Sinai, New York
Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 07-Ama-2026 · NCT06001450

Study of Efficacy and Adherence to Subcutaneous vs. Intravenous Vedolizumab in Patients With Inflammatory Bowel Disease Using a Novel Remote MONITORing Intervention

  • New York University, New York
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 08-Cam-2025 · NCT06750731

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.